Passkey Therapeutics Launches with Platform to Design Multifunctional Drugs

Bruce Beutel, PhD, who has worked in the drug development industry for over thirty years is ready for a change. He wants to move beyond the single target paradigm, in which a single molecule has a highly targeted effect on the function of one protein…